Persistence Market Research is released new forthcoming report on title "Peptic Ulcer Drugs Market: Global Industry Analysis and Forecast to 2020".

New York, NY -- (SBWire) -- 12/09/2014 --Peptic ulcer is a sore or hole in the lining of the stomach, duodenum or esophagus. Peptic ulcer is formed when the lining of the digestive system is corroded by acidic digestive juices. Peptic ulcer is the result of an imbalance between duodenum and digestive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. Gastric ulcer occurs inside the stomach whereas esophageal ulcer occurs inside the esophagus that carries food from throat to stomach. Duodenal ulcer occurs inside the upper portion of small intestine. Infections from helicobacter pylori bacteria, uses of nonsteroidal anti-inflammatory drugs, excess acid production from gastrinomas are some of the common causes of peptic ulcer. Stomach pain, bloating, heartburn, nausea and vomiting are some of the common symptoms for peptic ulcer. Bleeding from ulcer is the major symptoms for peptic ulcer. It is identified with the help of bloody and sticky stools. Peptic ulcer can be treated with the help of prescribed and over the counter drugs. Drugs used to treat peptic ulcer are antibiotics, proton pump inhibitors, histamine blocker, antacids and cytoprotective agents. Acid blockers include ranitidine (Zantac), cimetidine (Tagamet), famotidine (Pepcid) and nizatidine (Axid). Cytoprotective medication includes prescription and non-prescription based medications. Prescription based cytoprotective agent includes sucralfate (Carafate) and misoprostol (Cytotec). Non-prescription based cytoprotective agent includes bismuth subsalicylate (Pepto-Bismol). Peptic ulcers that are not healed with medications are known as refractory ulcer. Refractory ulcer usually occurs due to regular use of tobacco, resistance of helicobacter bacteria and regular use of pain relievers. In addition, stomach cancer is another cause for refractory ulcer.

Buy Full Report:
http://www.persistencemarketresearch.com/market-research/peptic-ulcer-drugs-market.asp

North America is dominating the global peptic ulcer drugs market due to rising number of people suffering from peptic ulcer. Asia is expected to show high growth rates in the next five years in global peptic ulcer drugs market. Asia Pacific countries such as India, China and Australia are expected to show high growth rate in peptic ulcer drugs market due to rising incidence of peptic ulcer. Some of the key factors driving the growth of the global peptic ulcer drugs market in developing countries such as Brazil, Argentina and Chile are increasing demand for anti-peptic ulcer drugs due to poor hygienic practices and sanitization in these countries.

In recent time there is increased use of anti-peptic ulcer drugs due to increasing number of patients suffering from helicobacter pylori bacteria infections. Increasing R&D investments and advancements in peptic ulcer therapies are some of the key factors driving the growth of the global peptic ulcer drugs market. In addition, rising aging population is also fuelling the growth of the global peptic ulcer drugs market. However, patent expiration of various drugs and high cost of drugs manufacturing are some of the factors restraining the growth of the global peptic ulcer drugs market.

Rising adverse effect of proton pump inhibitors could be a challenge for the growth of the global peptic ulcer market. Combination drug is one of the trends for the growth of the global peptic ulcer drug market. Some of the major companies operating in the global peptic ulcer market are AstraZeneca PLC, Daewoong Pharmaceutical Co., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Helicure AB and EUMEDICA.

Request Full Toc:
http://www.persistencemarketresearch.com/toc/3704

Key points covered in the report:

1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)

2) The report covers geographic segmentation

North America
Europe
Asia
RoW

3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020

4) The report provides company profiles of some of the leading companies operating in the market
The report also provides porters five forces analysis of the market.

Browse more market research articles
http://www.persistencemarketresearch.com/articles.asp

Browse more market research press releases
http://www.persistencemarketresearch.com/media-releases.asp

About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.